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Differentiation is the process by which tissues/organs take on their final, physiologically functional form. This process is mediated in part by
the silencing of embryonic genes and the activation of terminal, differentiation gene products. Mammalian kidney development is initiated when
the Wolffian duct branches and invades the overlying metanephric mesenchyme. The newly formed epithelial bud, known as the ureteric bud, will
continue to branch ultimately differentiating into the collecting duct system and ureter. Here, we show that Hoxb7-Cre mediated removal of β-
catenin from the mouse Wolffian duct epithelium leads to the premature expression of gene products normally associated with the differentiated
kidney collecting duct system including the water channel protein, Aquaporin-3 and the tight junction protein isoform, ZO-1α+. Mutant cells fail
to maintain expression of some genes associated with embryonic development, including several mediators of branching morphogenesis, which
subsequently leads to kidney aplasia or hypoplasia. Reciprocally, expression of a stabilized form of β-catenin appears to block differentiation of
the collecting ducts. All of these defects occur in the absence of any effects on the adherens junctions. These data indicate a role for β-catenin in
maintaining cells of the Wolffian ducts and the duct derived ureteric bud/collecting duct system in an undifferentiated or precursor state.
© 2007 Elsevier Inc. All rights reserved.Keywords: β-catenin; Wolffian duct; Ureteric bud; Precursor cell; Differentiation; CAKUT; Kidney development; Metanephros; WntIntroduction
The metanephric kidney is an essential organ composed
primarily of epithelial tubules and blood vessels. In the mouse,
metanephric kidney development initiates between embryonic
day (e) 10.5 and 11.0 when a caudal portion of the Wolffian duct
(WD) branches and invades the dorsally located metanephric
mesenchyme (MM). This epithelial branch, known as the
ureteric bud (UB), undergoes repeated rounds of branching
morphogenesis throughout the embryonic period halting shortly
after birth. The UB will give rise to the collecting duct system
(CD) and ureter in the mature organ. Defects in ureteric bud
branching lead to phenotypes ranging from complete aplasia to
hypoplasia and constitute some of the most common causes of⁎ Corresponding author. Fax: +1 214 648 2071.
E-mail address: Thomas.carroll@utsouthwestern.edu (T.J. Carroll).
0012-1606/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2007.11.016renal failure in humans (Shah et al., 2004; Woolf, 2006; Woolf
et al., 2004).
The metanephros develops in a centrifugal fashion with the
outer-most or cortical epithelia being the youngest and least
differentiated while the more internal or medullary epithelia are
the oldest and most differentiated. Morphological studies
suggest that the more distal/medullary kidney tubules of the
mouse metanephros become physiologically active around
e15.5 (Woolf and Yuan, 2003). Interestingly, the cortical
collecting ducts continue to branch while the medullary
collecting ducts are presumably functional in their capacity to
concentrate urinary filtrate. This suggests a fine balance
between signals that maintain the bud tips in an undifferentiated
(precursor) state while allowing the distal epithelium to mature.
Presumably, any defects in this balance would have repercus-
sions on the number of ureteric bud tips that form during
development and ultimately nephron endowment in an adult
kidney. Although recent studies have identified factors that
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differentiation of the ureter/collecting duct system, the pro-
cesses regulating precursor cell maintenance and maturity are
poorly understood (Airik et al., 2006; Brenner-Anantharam et
al., 2007; Yamaguchi et al., 2006).
β-Catenin is a multi-functional protein. In one of its roles, it
binds to the transmembrane protein E-cadherin and cytoplasmic
α-catenin to link the cell–cell adhesion complex known as the
adherens junctions (AJ) to the actin cytoskeleton. In flies
lacking the β-catenin homolog armadillo (arm), the adherens
junction protein E-cadherin fails to localize to the lateral
membrane of epithelia (Cox et al., 1996). Mutant epithelia also
show defects in apical/basal polarity, presumably as a result of
perturbed AJ formation/function (Cox et al., 1996). However, in
mice in which β-catenin has been ablated in specific tissues, no
defect in AJ formation has been witnessed, presumably due to
compensation by the closely related protein, γ-catenin, also
known as plakoglobin (Haegel et al., 1995; Murtaugh et al.,
2005).
A second function of β-catenin is to act as a transcriptional
co-regulator, primarily through interactions with the Lef/Tcf
family of transcription factors (Brembeck et al., 2006). In this
capacity, β-catenin has been shown to regulate multiple
cellular processes including cell proliferation, survival and
adhesion. Several studies have demonstrated roles for β-
catenin in the maintenance of stem or embryonic precursor
cells (DasGupta and Fuchs, 1999; Huelsken et al., 2001;
Kielman et al., 2002; Scheller et al., 2006; Zechner et al.,
2003). In addition, deregulation of β-catenin signaling has
been implicated in various human diseases, especially cancer
(Giles et al., 2003).
Recent analyses of β-catenin reporters and transcriptional
targets have suggested high levels of transcriptional activity in
the developing Wolffian duct and ureteric bud. However,
assessing the role of β-catenin in these tissues has been
hampered due to early embryonic lethality in null embryos
(Haegel et al., 1995; Perantoni, 2003). Here we report that WD/
UB/CD specific deletion of β-catenin leads to multiple defects
in urogenital development ranging from complete aplasia to
duplexed kidneys and cystic/dysplastic kidneys. Analysis of
mutant embryos demonstrates that β-catenin is necessary for
maintaining cells of the WD/UB in a precursor state. Mutant
cells show several signs of premature differentiation including
the precocious expression of the terminal tight junction protein
isoform, ZO-1α+ and the collecting duct water channel protein,
Aquaporin-3, accompanied by the loss of expression of several
branching regulators. These data demonstrate an essential role
for β-catenin in the formation and normal differentiation of the
mammalian urogenital system.
Materials and methods
Mouse strains
WD/UB specific deletion of β-catenin was accomplished by crossing mice
triply heterozygous for Hoxb7-Cre (Yu et al., 2002), β-catenin (Brault et al.,
2001), and the Rosa reporter (Soriano, 1999) to mice homozygous for the
conditionally inactive allele of β-catenin (ctnnb1tm2Kem). WD/CD specificactivation of β-catenin was accomplished by crossing mice carrying Hoxb7-
Cre to mice carrying an allele of β-catenin where exon 3 has been floxed
(Harada et al., 1999). Noon on the day of vaginal plug detection was
considered E0.5.
Wholemount expression analysis
Rosa reporter activity was assessed as previously described (Soriano,
1999). For in situ hybridization, tissues were post-fixed in 4% paraformalde-
hyde for 24 h at 4° prior to hybridization with antisense, digoxygenin labeled
mRNA probes. All probes examined have been previously described with
the exception of L1-Cam (cut with EcoRI and transcribed with T3
polymerase), Crumbs-3 (EcoRI/T7), lethal giant larvae homolog 2 (SalI,
T7) and the Kit ligand (SalI/T7). For mutant analysis, a minimum of six
wildtype (heterozygous) and six mutant embryos were analyzed. Hybri-
dized embryos were cleared in 80% glycerol and photographed using a
Nikon digital still camera (DXM1200) on a Nikon stereomicroscope
(SMZ1500).
Immunohistochemistry
e11.5 and P1 embryos were fixed in 4% paraformaldehyde at 4 °C
overnight, washed 3 times in PBS, equilibrated in 30% sucrose then imbedded
in OCT and flash frozen on dry-ice. Tissue was sectioned at 10 uM on a
cryostat and sections were stored at −80 °C until usage. Thawed sections were
boiled for 10 min in 10 mM Tris, pH 8.0 and 5 mM EDTA then incubated with
primary antibodies to acetylated-α-tubulin (mouse, Sigma, T 5168), β-catenin
(rabbit, Chemicon, AB19022, rabbit, abcam, ab2982 and mouse, Sigma
c7207), de-phosphorylated β-catenin (mouse, Upstate Cell Signaling Solu-
tions), γ-catenin (goat, Santa Cruz, Sc-1497), β-tubulin (mouse, Sigma,
T4026), Scribble (goat, Santa Cruz,), PCNA (mouse, zymed, 18-0110), Ki-67
(rabbit, Novo-Castra, NCL-Ki67p), Pax2 (rabbit, Covance, PRB-276P), pan-
cytokeratin (mouse, Sigma, C2562), E-cadherin (Rat, Zymed, 13-1900 and
rabbit, a gift from Rolf Kemler), Laminin (Rabbit, Sigma, L9393), DBA lectin
(Sigma), Occludin (Rabbit, Zymed, 71-1500) ZO-1α+ (Rat, Chemicon,
Mab1520 [Note; Chemicon no longer makes this antibody. We have tried
another version from Hycult Biotechnology but have been unable to get this
antibody to work in wax or frozen sections, with and without antigen
retrieval.]), ZO-1 (rabbit, Zymed, Cat. #40-2300), aPKC (rabbit, Santa Cruz,
Cat. #sc-216), Ezrin (rabbit, Upstate Cell Signaling Solutions, Cat. #07-130,
1:100), UT-A, Aqp-2 and 3 (rabbit, provided by Mark Knepper) and Aqp-9
(rabbit, Alpha Diagnostic International, Cat. #AQP91-A, 8 ug/ml). All
antibodies were diluted 1:500 unless otherwise indicated. The secondary
antibodies were Alexafluor 488, 568 and 633 (Molecular Probes). Tissues were
mounted in VectaShield with Dapi (Vector labs). For characterization of ectopic
buds, only sections caudal of the mesonephric tubules and cranial of the
hindlimb bud were analyzed and sections from a minimum of 3 animals were
examined. Sections were viewed and photographed on a Zeiss LSM510
Axioplan inverted confocal microscope.
Transmission electron microscopy
Thick (1 uM), transverse sections were cut of plastic imbedded wildtype and
mutant e11.5 Wolffian ducts and stained with toluidine blue. Mutant cells are
distinguishable from wildtype histologically by the presence of numerous large
vacuoles and decreased apical cytoplasm in mutant cells. When clear ectopic
buds were identified in thick sections, thin sections were cut from the adjacent
tissue and viewed with a FEI Tecnai G2 Spirit microscope. The above-
mentioned histological criteria were used to distinguish wildtype from mutant
epithelia.
Organ culture
Organ culture was performed as previously described (Carroll et al., 2007).
Briefly, e10.5 urogenital systems were dissected out and cultured for 48 h in
DMEM with 10% FBS and either 10 ug/ml anti-GDNF, 200 ng/ml mouse
recombinant Dkk1 (both from R&D Systems) or 10 ug/ml anti-β-galactosidase
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rinsed in PBS and either mRNAwas extracted for RT-PCR or the tissues were
fixed for β-galactosidase staining, in situ hybridization or antibody staining.
GDNF treated issues were hybridized with an antisense probe to Pax-2 or Wnt9b
in order to assess the extent of UB branching.
Statistical analysis
To measure basal to apical distance, tissues were stained with anti-laminin
and anti-β-catenin antibodies and photographed at the same magnification on a
confocal microscope. The cell height was measured using a digital micrometer.
Measurements were only made on cells that were clearly continuous with the
basement membrane and a line was drawn from (and perpendicular to) the
basement membrane to the luminal membrane. In all cases, we measured cells
only within approximately 100 uM of the hindlimb bud and only on the medial
side of the tubule to account for any spatial differences in cell height. A total of
62 mutant and 66 wildtype cells were measured from 4 animals.
To measure proliferation rates, tissues were stained with Dba lectin,β-catenin,
Ki67 and Dapi. Only nuclei from Dba lectin positive epithelia were counted. In
the case of mutant epithelia, only cells that were clearly identified as β-catenin
mutant (by immunohistochemistry) were included in the statistical analysis. For
e11.5, a total of 95 wildtype (6 individual embryos) and 106 mutant cells (6
embryos), for e12.5, 815 wildtype (4 individuals) and 523 mutant (4 individuals)
cells, for 14.5, 970 wildtype (5 individuals) and 1630 mutant (7 individuals) cells
and for P1, a total of 457 (190 β-catenin +, 267 β-catenin −) and 442 cells from 7
mutant and 5 wildtype individuals, respectively, were counted. P values were
calculated using a Student T-test. Values presented are the average and the
standard deviation. A similar technique was used to measure apoptosis. Apoptotic
cells were identified using TUNEL and an anti-caspase antibody.Results
In the past several years, a number of groups have
engineered mice that report Lef/Tcf (and presumably β-catenin)Fig. 1. Sagittal sections through e11.5 β-catenin mutant Wolffian ducts. β-Catenin s
Ducts have been double stained with antibodies for Pax-2 (single channel red in pane
indicate ectopic epithelia.transcriptional activity (DasGupta and Fuchs, 1999; Iglesias et
al., 2007; Jho et al., 2002; Leung et al., 2002; Lustig et al., 2002;
Maretto et al., 2003). At least three of these mouse strains report
transcriptional activity in the embryonic kidney and in all cases
expression is high in the WD and UB (Iglesias et al., 2007; Jho
et al., 2002; Leung et al., 2002; Lustig et al., 2002; Maretto et
al., 2003).
To examine a potential role for β-catenin in the context of the
WD/UB/CD system, we took advantage of a conditionally
inactive (floxed) allele of β-catenin and a Cre driver line that we
previously generated (Hoxb7-Cre) (Brault et al., 2001; Yu et al.,
2002). Hoxb7-Cre is expressed in the WD/UB/CD lineage from
e9.5 through birth (Yu et al., 2002). Mice carrying the Hoxb7-
cre transgene, the ROSA reporter (Soriano, 1999) and one
mutant allele of β-catenin (Hoxb7-cre;β-catenin+/−; ROSA)
were crossed to mice homozygous for the β-catenin conditional
allele (β-cateninc/c) (Brault et al., 2001) to generate Hoxb7-
cre; β-catenin−/c embryos, from hereon referred to as β-catenin
mutants.
To test the efficiency of Hoxb7-Cre mediated excision, we
characterized the expression of β-catenin protein in wildtype
and mutant tissue. In wildtype (wt) e11.5 embryos, β-catenin
was expressed at high levels on the baso-lateral side of the
WD/UB epithelium and at lower levels throughout the
cytoplasm (Data not shown). Nuclear β-catenin was not
detected. Although Hoxb7-Cre appears to be active throughout
the WD of mutants and wildtype embryos (as visualized by
ROSA reporter activity, Figs. 2A–F), staining of mutants
showed that β-catenin protein was removed in a mosaic
fashion in the WD epithelium (Figs. 1Aʺ and Bʺ). This appearstaining shows that extruded epithelia can be either wildtype (A) or mutant (B).
ls A′ and B′) and β-catenin (single channel green in panels Aʺ and Bʺ). Arrows
Fig. 2. Development of the Wolffian duct and ureteric bud at e11.5 and e12.5.
Lac-Z stained e11.5 (A, C, E) and e12.5 (B, D, F) Hoxb7-Cre; β-catenin+/c;
ROSA+/− (wildtype, A and B) and Hoxb7-Cre; β-catenin−/c;ROSA+/− (mutant,
C–F) urogenital systems. Hoxb7-Cre is active in the Wolffian duct (red arrows)
and ureteric bud (black arrows) of e11.5–12.5 urogenital systems (A and B).
β-Catenin mutant collecting ducts show multiple ectopic bud structures
branching from the Wolffian duct (arrowheads in panels C–F) and defective
branching of the ureteric buds (black arrows in panels C–F).
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locus relative to the ROSA-26 locus. The level of mosaicism
varied considerably, with between (approximately) 10% and
100% of the WD cells lacking detectable β-catenin protein at
e11.5 (not shown).
Histological analysis indicated that mosaic Wolffian ducts
formed ectopic bud like structures (Figs. 1A and B). Surpris-
ingly, there did not appear to be a correlation between the
presence and absence of detectable β-catenin and the formation
of these ectopic epithelia (Figs. 1A and B). When clearly
defined, distinct ectopic buds were present, they were either
wildtype for β-catenin or mutant, but not mosaic. Ducts that
were exclusively composed of mutant cells were relatively
normal looking with no ectopic buds (data not shown).
Characterization of ectopic buds in β-catenin mutants
To gain a better understanding of the mechanisms that led to
the formation of the ectopic buds, we examined the develop-
ment of mutant Wolffian ducts and ureteric buds from e10.5 to
12.5.
In wt embryos, a caudal portion of the WD adjacent to the
hindlimb begins to bud dorsally around e11.0, invading the
overlying metanephric mesenchyme. At e11.5, the bud has
invaded the MM and branched once within it forming a T-
shaped structure (Fig. 2A). Over the next several days, the UB
will continue to branch eventually giving rise to the collecting
duct system and ureter of the mature kidney (Fig. 2B). At e10.5,
both wildtype and mutant WDs were smooth and uniform (not
shown) although the mutant ducts did not swell at the caudal
end in 2/3 embryos. By e11.5, β-catenin mutant embryos
displayed several small, ectopic bud-like structures along the
entire length of the WD (26/30, Compare Figs. 2A with C and
E). The ectopic buds were not restricted to the dorsal side of the
epithelium but instead protruded from the WD randomly. In
some individuals, the more caudal ectopic buds invaded the
MM alongside the endogenous UB (Fig. 2E), however, in 4/30
instances no ureteric bud had invaded the MM by e11.5 (not
shown). At e12.5, ectopic buds were still evident, however
those that formed on the ventral side of the WD and those that
were significantly anterior of the MM had ceased to grow and at
least in some cases appeared to have completely separated from
the WD (compare Fig. 2B with D and F). In 7/9 cases, the
endogenous UB showed greatly reduced branching within the
mutant mesenchyme at e12.5 (Figs. 2D and F).
Removal of β-catenin from the Wolffian duct/ureteric bud
results in multiple defects in the urogenital system
To determine the consequences of β-catenin removal on
formation of the urogenital system, we examined the urogenital
systems of newborn pups derived fromHoxb7-cre;β-catenin+/−;
ROSA and β-cateninc/c intercrosses. Mutants were born in the
expectedMendelian ratio, however the majority died within 48 h
of birth. Out of 71 progeny from 10 litters, only two mutant
animals survived past post-natal day 5 (approx. 18 expected)
suggesting early post-natal lethality.As predicted from our early analysis, comparison of wildtype
(Figs. 3A and D) and mutant (Figs. 3B, C and E) P1 urogenital
systems revealed a range of phenotypes, from extreme
hypoplasia/aplasia (17/28, Fig. 3C) to dysplastic/cystic kidneys
(11/28, Figs. 2B and E). In all cases, ureteric bud branching, as
determined by the number of lac-Z stained tips, was
significantly reduced. In the most severe cases, no ureter or a
single unbranched ureter was present (Fig. 3C and not shown).
The ureters were dilated and tortuous and frequently appeared
obstructed (Figs. 3B, C and H). Frequently (8/28), more than
one ureter (ectopic) was observed accompanied by a duplexed,
hypoplastic kidney (Fig. 3B).
Fig. 3. β-Catenin mutant phenotypes in P1 kidneys. Wholemount Lac-Z stained (A–E) and H and E stained (F–H) P1 kidneys from Hoxb7-Cre; β-catenin+/c; Rosa+/−
(wildtype, A, D and F) and Hoxb7-Cre; β-catenin−/c; Rosa+/− (mutant, B, C, E, G and H) pups. Panel B shows a mutant with duplexed kidneys (blue arrows) and
ectopic ureters (black arrows). Panel C shows a severely dysplastic kidney with a single ureter (black arrow). Panels D and E show high magnification images of panels
A and B respectively. Note the dilated collecting ducts in panel E (black arrow). Sections through wildtype (F) and a cystic (G) and severely dysplastic (H) kidney. Note
the expanded renal pelvis in panel G (asterisk).
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3F) had normal appearing kidneys while mutants were cystic
and frequently showed a greatly expanded renal pelvis
(hydronephrosis, Fig. 3G). Dilated/cystic epithelia were visible
by e14.5 and were always confined to the UB/CD lineage (Fig.
3E and not shown). Cysts frequently had multi-layered polyps
extending into the lumen (not shown). In all cases observed, the
polyps were made up of wildtype cells adjacent to a mutant
epithelium (not shown). In examples of extremely hypoplastic
mutants, the ureteric buds were surrounded by condensed,
undifferentiated mesenchyme (Fig. 3H). Females lacked a
uterus and upper vagina while males had an abnormal, dilated
epididymis and vas deferens (data not shown).
The variability in β-catenin excision seen in early
embryonic stages was still evident at birth with some kidneys
containing little or no β-catenin in their collecting ducts while
others were highly mosaic (data not shown). The degree of β-catenin excision correlated with the severity of the phenotype
with aplastic or severely hypoplastic organs possessing few or
no β-catenin positive cells within the ureteric bud derivatives
while hypoplastic kidneys showed varying degrees of mosai-
cism (data not shown).
Molecular analysis of ectopic bud formation
To address the mechanism behind the β-catenin mutant
phenotype, we characterized the epithelia at a molecular level.
Formation of duplexed kidneys is thought to be caused by
ectopic activation of ureteric bud branching determinants,
especially members of the Ret/GDNF signaling axis, within the
anterior Wolffian duct (Basson et al., 2005; Grieshammer et al.,
2004; Kume et al., 2000; Towers et al., 1998). Inappropriate
activation of the branching pathway within the collecting duct
system would also explain the cystic tubules observed in
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localized activation of this pathway. To determine if β-catenin
removal was affecting the branching pathway, we looked at the
expression of a number of regulators of this process in the
developing ureteric bud.
At e10.5–11.5, c-ret mRNA is expressed throughout the
wildtype Wolffian duct and ureteric bud, with highest levels in
the branching tips of the bud (Fig. 4A and not shown).
Expression analysis revealed that at e10.5, ret mRNA was
expressed normally in the WD epithelium (not shown) but byFig. 4. Molecular characterization of β-catenin mutant Wolffian ducts and ureteric bud
D, G, H, K, L, O, P) wildtype (A, C, E, G, I, K, M, O) and mutant (B, D, F, H, J, L, N
(I–L) and GDNF (M–P). In panel B, the black arrows indicate the wildtype Wolffian d
red arrows indicate ectopic epithelial buds. Black arrowheads indicate the wildtype m
in panels A–H, metanephric mesenchyme in panels I–P).e11.5, expression had become mosaic in the mutant WD (Fig.
4B). In 7/11 e11.5 mutant embryos, ret expression looked
relatively normal in the UB although in three cases, the UBs did
not appear to form ampullary tips (Fig. 4B). In the other 4
embryos, ret expression was undetectable and no UB had
formed (data not shown). In wildtype embryos at e12.5, ret
expression has refined to the tips of the UB (Fig. 4C), while in
mutants expression was variable. 3/9 embryos had no detectable
ret expression in the UB. 4/9 had abnormally branched UBs
with expression normal in some epithelia and reduced or absents. Wholemount in situ hybridization of e11.5 (A, B, E, F, I, J, M, N) and 12.5 (C,
, P) urogenital systems stained with antisense c-Ret (A–D), Wnt11 (E–H), Pax2
uct while the red arrows indicate areas that show no c-Ret expression. In J and L,
etanephros and the red arrowheads indicate the mutant metanephros (ureteric bud
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branching and ret expression. Immunofluorescent/antisense
mRNA co-stainings of e12.5 mutant embryos showed that β-
catenin removal from the UB/CD was mosaic and that cells that
retained normal levels of c-ret mRNA also had normal levels of
β-catenin protein including some well-formed ectopic buds (not
shown).
Although the above data suggested that there was a loss of c-
ret expressing cells in β-catenin mutants, it was still possible
that the branching pathway was activated somewhere down-
stream of the receptor. Wnt11 has been suggested to be a
downstream target of GDNF/Ret signaling (Pepicelli et al.,
1997). Normally expression is confined to the tips of the
branching ureteric bud and no expression is seen in the wildtype
WD at e11.5 or 12.5 (Figs. 4E and G and data not shown).
Similar to our observations of ret expression, Wnt11 levels in
the endogenous UB were reduced or absent in β-catenin
mutants at e11.5 and 12.5 (Figs. 4F and H). Ventral/lateral
branches and ectopic anterior buds, whether they were
composed of mutant or wildtype cells, never expressed Wnt11
at detectable levels although in one case, where there was a
clearly duplexed kidney at e12.5, the ectopic buds that resided
within the MM did express Wnt11 (not shown).
β-Catenin mutant cells also failed to express or maintain
expression of two additional ureteric bud markers, Emx-2 and
Sox-9 (data not shown). Further, formation of the ectopic
epithelia did not depend on Ret/GDNF signaling as co-culturing
mutant Wolffian ducts with a function blocking GDNF antibody
did not affect formation of these structures while it did block
formation of the ureteric bud (data not shown).
These data suggested that β-catenin was necessary for the
expression of several factors that regulate branching of the UB.
In order to address whether this was specific to genes expressed
in the bud tips or was a general defect in specification or
maintenance of the WD and/or collecting ducts, we examined
the expression of several factors whose expression is not
restricted to the UB tips.
Pax2 mRNA and protein are expressed in both the WD/UB
system and the MM (Dressler et al., 1990). Expression in the
WD/UB is not spatially restricted although protein levels are
highest at the branching tips. Pax2 transcript and protein
expression was examined in β-catenin mutants (Figs. 4I–L and
Figs. 1A and B, respectively). Pax2 transcripts were detected in
the Wolffian duct and ectopic ureteric buds and in the MM of β-
cateninmutants (compare Figs. 4I and K to J and L). We did not
detect mesenchymal expression of Pax2 adjacent to the more
anterior or non-dorsal ectopic buds in vivo (Figs. 4J and L).
However, in 4/6 cases, the MM domain of Pax2 expression was
greatly reduced by e12.5 (Fig. 4L), most likely due to attenuated
branching morphogenesis. Similar results were seen with
antibodies to Pax2 although the levels of the protein appeared
to be slightly decreased in β-catenin mutant cells compared to
wildtype (Figs. 1A′ and B′). The decreased expression of Pax2
in the mesenchyme correlated with decreased expression of the
Ret ligand, GDNF (Figs. 4N and P), a gene previously shown to
be a transcriptional target of Pax2 (Brophy et al., 2001). No
obvious deficits were seen in the expression of several othergeneral WD markers including Crumbs3, kidney specific
cadherin (Cdh16), Lethal giant larvae homolog 2, L1Cam,
Hnf1β and Sprouty1 (not shown) (Basson et al., 2005; Debiec et
al., 2002; Gavert et al., 2005).
Proliferation rates are unchanged in early stage β-catenin
mutant cells
Previous studies have shown that β-catenin regulates the rate
of cell proliferation (He et al., 1998; Shtutman et al., 1999).
Local changes in the rates of proliferation could explain the
formation of ectopic buds and cysts in mutants. To determine if
proliferation rates were affected by loss of β-catenin, we
calculated proliferation rates in e11.5, 12.5, 14.5 and 18.5
wildtype and mutant WDs, UBs and CDs. β-catenin mutant
cells (i.e. cells not expressing detectable levels of β-catenin
protein) within the WD/UB did not show statistically significant
differences in the rate of proliferation compared to wildtype at
e11.5 (20±9% vs. 16±10% for Ki67, N=6, P=0.551) or 12.5
(8.65±11.7%, N=19 vs. 8.5±17.5% N=23, for Ki67, P=0.9).
However, at e14.5 and P1, Ki67 staining indicated enhanced
rates of cell division in mutant collecting duct cells relative to
wildtype (13.2±11.0%, N=38 vs. 4.33±5.12%, N=23,
P=0.001 for e14.5 and 17.8±0.08%, N=7, vs. 1.8±0.01%,
N=5, P=0.001 P1, mutant vs. wildtype respectively).
At P1, some epithelia were still mosaic in their removal of β-
catenin. Comparison of the proliferation rates of wildtype and
mutant cells within P1 cysts from a mutant animal showed no
statistical differences (15.8±0.1% vs. 17.8±0.1% respectively.
N=7, P=0.76) suggesting that the factor(s) leading to increased
proliferation at later stages was non-cell autonomous and most
likely a secondary consequence of ureter/collecting duct
obstruction. TUNEL analysis revealed no statistical differences
in cell death between wildtype and mutant WD/CD epithelia at
e11.5, 12.5 and 14.5 although there did appear to be increased
cell death in the adjacent mesenchyme at e12.5 and 14.5 (not
shown). These data suggest that changes in the rates of cell
proliferation/survival were not responsible for the ectopic
budding phenotype although increased rates of cell proliferation
likely contributed to cyst formation.
β-Catenin null cells show no signs of adherens junction defects
The above data suggest that ectopic bud formation is not the
result of activation of the ureteric bud branching pathway or
changes in proliferation rates. A third possibility is that mutant
cells are differentially adhesive relative to wildtype cells (i.e.
mutant cells are more adhesive to other mutant cells than to
wildtype and vice versa). β-Catenin has previously been
implicated in cell adhesion through its association with E-
cadherin at the AJs. In order to determine whether the mutant
Wolffian ducts displayed normal AJ formation, we examined
the expression of E-cadherin as well as Scribble, a protein
whose localization at the AJs requires E-cadherin, in mutant
cells (Navarro et al., 2005). Mutant cells expressed both
proteins at similar levels and in a similar domain to wildtype
cells (Figs. 5Aʺ and Bʺ and data not shown).
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ablation, plakoglobin, has been shown to compensate for
mutant β-catenin in adherens junction formation/function
(Haegel et al., 1995). To test whether this protein might be
compensating for β-catenin in adherens junction formation in
the developing kidney, we examined its expression in
wildtype and mutant epithelia. Plakoglobin is expressed at
low levels on the baso-lateral side of the WD/UB epithelium
in wild type and mutant kidneys (Figs. 5C′ and D′).
Plakoglobin continues to be expressed in mutant cells al-Fig. 5. Adherens junctions are not disrupted in β-catenin mutants. Wildtype (A, C, E)
A′ and B′), E-cadherin (single channel in panels Aʺ, Bʺ, Cʺ and Dʺ) and β-catenin (
mutant epithelia (arrows in panel B) express E-cadherin and plakoglobin normally.
epithelia (arrowhead in panel F) relative to wildtype epithelia (E and arrow in panel F
panels G and H) are morphologically undisturbed in mutant epithelia (H) relative tothough protein levels appear to be slightly increased relative
to wildtype (compare Fig. 5C′ and D′).
Finally, we examined wildtype and mutant epithelia via
transmission electron microscopy. 1 uM transverse plastic
sections of wildtype and mutant embryos were sectioned and
stained with toluidine blue. Mutant sections were examined for
the presence of clear ectopic epithelia (Fig. 5F). Mutant
epithelia were histologically distinct from wildtype due to
lighter cytoplasmic staining and the presence of numerous small
vacuoles (arrowhead in Fig. 5F). Upon identification of sectionsand mutant (B, D, E, F, H) stained for pan-cytokeratin (single channel in panels
single channel in panels A‴, B‴, C‴ and D‴) and plakoglobin (C′ and D′) show
Toluidine blue stained sections (E and F) show histology of mutant extruded
). Transmission electron microscopy showing the adherens junctions (arrows in
wildtype (G). Magnification in panels G and H is approx. 60,000×).
Fig. 6. β-Catenin mutant cells show normal apical/basal polarity. Wildtype (A, C
and E) and mutant (B, D, F and G) e11.5 Wolffian ducts triple stained for the
apical membrane marker aPKC (red), β-catenin (green) and Dapi (blue) in
panels A and B, the baso-lateral membrane marker E-cadherin (red), the apical
cytoskeletal marker Ezrin (green) and β-catenin (not shown) in panels C and D
or the basal lamina marker laminin (red), β-catenin (green) and Dapi (blue) in
panels E–G. β-catenin mutant epithelia are indicated by dotted white lines in
panels B and D. Panels A–D are 1000×. Panels E–G are 630×.
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were cut from the adjacent tissue and processed for transmission
electron microscopy. At the ultra-structural level mutant
epithelia possessed adherens junctions similar to wildtype
(compare Figs. 5G and H). These data suggest that formation of
ectopic epithelia is not due to defects in AJ formation or
maintenance.
Mutant cells show normal apical/basal polarity
Previous studies have suggested that β-catenin regulates
apical/basal polarity of epithelia. It seemed possible that defects
in this process could lead to differential cell adhesion and the
formation of ectopic buds. To address whether epithelial
organization was affected by removal of β-catenin, we
examined the expression of two apical epithelial markers,
atypical protein kinase C (aPKC) and the actin cytoskeleton-
associated protein, ezrin, as well as the basal lamina protein,
laminin, in wildtype and mutant tissues (Berryman et al., 1993;
Horne-Badovinac et al., 2001).
At all stages examined, aPKC, ezrin and laminin expression
was indistinguishable between wildtype and β-catenin mutant
cells (Figs. 6A–G). In fact, completely segregated mutant
epithelia expressed apical aPKC and were surrounded by an
intact basal lamina as assessed by laminin and periodic acid
Schiff's staining and electron microscopy (Figs. 6B, G and not
shown). These data suggest that the mutant epithelium is
properly organized/polarized.
β-Catenin mutant cells show signs of premature differentiation
Cell to cell adhesion is largely regulated by the adherens
junctions, tight junctions (Tjs) and desmosomes and their
associated proteins (Balda and Matter, 2003). As discussed, the
AJs were grossly unaffected in mutant cells and we could not
detect differences in the expression of several AJ associated
proteins and/or mRNAs in mutants including E-, Ksp and N-
cadherin and scribble-1 (Fig. 5 and not shown). We could not
detect the presence of desmosomes in wildtype or mutant WDs
at e11.5 by molecular or EM analysis (not shown) suggesting
this structure was not playing a role in the observed differential
cell adhesion.
The tight junctions consist of a number of transmembrane
proteins, the claudins, jams and occludins, that are connected to
the actin cytoskeleton by the cytoplasmic zona occludens (ZO)
proteins, ZO-1, 2 and 3 (Matter et al., 2005). The ZO-1 protein
consists of two isoforms, ZO-1α+ and −, that differ in the
presence of an alternatively spliced exon in their C-terminus
(Balda and Anderson, 1993; Willott et al., 1992). We initially
examined the expression of the α+ isoform with an exon
specific antibody as previous work suggested that this protein
was expressed in virtually all epithelia, including those of the
urogenital system (Komiya et al., 2005). Surprisingly, our
analysis showed ZO-1α+ was not expressed in the wildtype
WD or UB through at least e12.5 (Figs. 7A, 8A and not shown).
At e14.5, ZO-1α+ was detectable in the distal collecting ducts
and ureter but not in the cortical collecting ducts or ureteric budtips (Fig. 7B). At P1, the majority of collecting duct epithelia
expressed ZO-1α+ although some UB tips still did not (Fig. 7C
and not shown). The areas of ZO-1 α+ expression in wildtype
embryonic kidneys corresponded to the most differentiated
portions of the collecting duct system and the cells that showed
low levels of transcriptionally active β-catenin as assessed by
low level expression of the β-catenin target gene, Axin2 (Figs.
7D and E), and lower cytoplasmic levels of (de-phosphorylated)
β-catenin protein (Fig. 7F) (Iglesias et al., 2007; Jho et al.,
2002).
Fig. 7. ZO-1α+ expression inversely correlates with high levels of β-catenin activity in the developingWD and ureteric buds. Sections of e11.5 (A), 14.5 (B and F) and
P1 (C) Wolffian ducts (A) and kidneys (B–C and F) stained with antibodies to the WD/UB/CDmarker cytokeratin (blue), ZO-1α− (red) and ZO-1α+ (green) in panels
A–C or a de-phosphorylated beta-catenin antibody (green in panel F). ZO-1α+ is not expressed in the e11.5 and 12.5 WD and ureteric bud (arrow in panel A and data
not shown). ZO-1α+ expression is detectable in the e14.5 CD (white arrow in panel B) but not in the proximal tips of the UB (arrowhead in panel B). The majority of
the UB/CD system is ZO-1α+ positive at P1 (arrows in panel C). ZO-1α+ is expressed in cells that lack high β-catenin transcriptional activity as indicated by the
expression of Axin2 mRNA and excluded from cells with the highest levels of active (de-phosphorylated) β-catenin (arrowhead in panel F). Axin-2 is expressed
throughout the e11.5 Wolffian duct (black arrow in panel D) and ureteric bud (black arrowhead in panel D) but only in the ureteric bud tips at e14.5 and P1 (black
arrowhead in panel E and not shown).
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both the WD and UB at e11.5 and 12.5 (Figs. 8B, D, E and G
and not shown). To ascertain whether this was a general effect
on the tight junction associated proteins, the expression of the
alternative isoform of ZO-1 (referred to as ZO-1α−) and an
additional tight junction marker, occludin, was also examined.
Both proteins were expressed normally in wildtype and mutant
WD and UB/CD at e11.5, 12.5, 14.5 and P1 (data not shown).
The premature expression of ZO-1α+ in β-catenin mutant
cells and the loss of expression of factors implicated in
precursor cell maintenance (including Sox9) suggested that β-
catenin was required to maintain cells of the branching ureteric
bud in an undifferentiated or precursor state. Previous studies
have shown a role for β-catenin in the maintenance of precursor
cells in multiple organ systems as well as in embryonic stem
cells (Zechner et al., 2003). To test whether β-catenin was
necessary for maintenance of precursors in the WD/UB, we
examined the expression of a bona fide marker of the
differentiated collecting duct, the water channel protein,Aquaporin-3 (Aqp-3) (Yamamoto et al., 1997). Similar to the
case with ZO-1α+, Aquaporin-3 protein was not detectable in
the wildtype WD or UB/CD from e11.5–14.5 (Fig. 8F and not
shown) but was expressed in β-catenin mutant cells of e11.5
WDs (6/10, Fig. 8G).
Importantly, mutant cells that were still part of an intact but
mosaic WD expressed ZO-1α+ and Aqp-3 in a cell autonomous
fashion and wildtype cells from β-catenin mutant embryos
never expressed either protein, even if they were part of an
extruded epithelial bud or cyst (not shown). These data suggest
that the premature differentiation is due to loss of β-catenin, not
epithelial extrusion. To confirm that the premature differentia-
tion was directly caused by a defect in β-catenin signaling, we
cultured e10.5 Wolffian ducts for 48 h in the presence of the
canonical Wnt antagonist, Dkk1. Dkk1 treated ducts showed
reduced branching of the ureteric bud (not shown) and
expressed high levels of ZO-1α+ and Aqp-3 relative to ducts
treated with BSA (Figs. 8H–O). However, we did find that
cultured ducts, in contrast to the situation in vivo, did express
Fig. 8. Blocking β-catenin function leads to the premature production of differentiation factors. Transverse sections through the Wolffian ducts of wildtype (A, C, F) or
mutant (B, D, E, G) embryos. (A–B) Wolffian ducts triple stained for β-catenin (green), ZO-1α+ (red) and Dapi (blue). Note the expression of ZO-1α+ only in the
β-catenin mutant epithelia (outlined cells in panel B). (C–E) Wolffian ducts stained for ZO-1α+ (red) and β-catenin (blue). Once again, β-catenin is only in the mutant
cells, even when they are still part of an intact but mosaic Wolffian duct (E). Panels F, G, Wolffian ducts stained with, aquaporin-3 (green), ZO-1α+ (red) and β-catenin
(blue). Note the expression of Aqp-3 in the β-catenin mutant cells but not in wildtype cells from the same duct (arrow in panel G). β-Catenin mutant cells are outlined
with dotted line in all images. Panels H–O show transverse sections through e10.5Wolffian ducts cultures for 48 h in the presence of 200 ng/ml BSA (H, J, L and N) or
recombinant Dkk1 (I, K, M and O) stained with ZO-1α+ (Red in panels H–K. Panels H and I show single channel.), Aqp-3 (Red in panels L–O. Panels L and M show
single channel.) and cytokeratin (green in panels J, K, N and O). Panels A–G are 1000×, panels H and I are 630×.
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that some factor required to maintain these cells in a fully
undifferentiated state is missing from the culture system.
Interestingly, β-catenin mutant cells did not express other
markers of the terminally differentiated collecting duct system,
including Aquaporin-2, the urea transporter (UTA-1) or the
renal outer medullary potassium channel protein (ROMK) or a
marker of the terminally differentiated male reproductive tract,
Aqp-9, suggesting that mutant cells represented an inter-
mediate step in Wolffian duct/ureteric bud differentiation (not
shown).Overexpression of a stabilized form of β-catenin in the
collecting duct system blocks the expression of differentiation
products
The loss of β-catenin activity correlates with the expression
of differentiation products. We therefore hypothesized that
overexpression of β-catenin in the developing collecting duct
system would prevent the expression of differentiation markers.
To test this hypothesis, mice carrying the Hoxb7-Cre transgene
were crossed to mice carrying an allele of β-catenin that has
lox-p sites flanking exon 3. Exon 3 carries several serine and
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the protein for degradation. Removal of this exon results in
expression of a stabilized form of β-catenin.
Mice driving expression of stabilized β-catenin in the
collecting ducts die within 24 h of birth. The majority of mutant
pups completely lacked a kidney, although some possessed
hypoplastic/cystic kidneys (Fig. 9B and data not shown). We
examined the expression of ZO-1α+, Aqp-3 and β-catenin in
the hypoplastic kidneys. Overexpression of stabilized β-catenin
strongly correlated with decreased expression of Aqp-3
throughout the collecting duct system while ZO-1α+ levels
appeared to be largely unaffected (compare Figs. 9C and D). We
also examined the expression of Aqp-2 in hypoplastic kidneys.
Although Aqp-2 was not ectopically expressed in mice lacking
β-catenin, we hypothesized that stabilization of β-catenin
would block production of many, if not most, differentiation
products. Similar to the case with Aqp-3, mice overexpressing
β-catenin in their collecting ducts had greatly reduced levels of
Aqp-2 (compare Figs. 9E and F). These data suggest thatFig. 9. Expression of a stabilized form of β-catenin leads to hypoplasia and a
lack of differentiation. Wholemount (A, B) and sections (C–F) of urogenital
systems from P1 β-catex3fl/+ (A, C, E) or Hoxb7cre;β-catex3fl/+ (B, D, F).
Sections have been stained with antibodies to Aqp-3 (green), ZO-1α+ (red) and
β-catenin (blue) in panels C, D or Aqp-2 (green), ZO-1α+ (red) and β-catenin
(blue) in panels E, F. Collecting ducts of mice expressing an activated form of
β-catenin show greatly decreased levels of Aqp-2 and 3. Arrows in panels A and
B indicate the kidneys.continued expression of β-catenin blocks some aspects of the
differentiation process.
Discussion
Although a role for β-catenin in kidney development and
disease has long been hypothesized, genetic evidence has been
lacking. Two recent studies revealed a requirement for this
factor in the mesenchymal to epithelial transition that leads to
the formation of the renal vesicles (Park et al., 2007; Schmidt-
Ott et al., 2007). However, the recent characterization of β-
catenin reporters in developing kidneys suggests that this
molecule has high transcriptional activity in a distinct cell
lineage, the Wolffian duct, and its derivative, the ureteric bud
(Iglesias et al., 2007; Jho et al., 2002; Maretto et al., 2003). To
determine a role for β-catenin in the development of these
tissues, we analyzed mice carrying a Hoxb7-Cre transgene and a
floxed allele of β-catenin (catnnbflox). Hoxb7-Cre mediated
removal of β-catenin led to multiple defects in the urogenital
system including complete aplasia and varying degrees of
hypoplasia and cystic dysplasia.
Kidney aplasia/hypoplasia is a relatively common human
disorder that is thought to be the result of a failure to initiate the
proper developmental programs. Based on several pieces of
data, we suggest that these phenotypes in β-catenin mutants are
caused by a failure to maintain cells of the ureteric bud tips in a
precursor or undifferentiated state. First, β-catenin mutant cells
showed several signs of premature differentiation including the
precocious expression of ZO-1α+ and Aquaporin-3 and
reduced levels of Pax-2 mRNA and protein as well as the loss
of several branching markers (e.g. Ret, Wnt11, Emx-2 and Sox-
9). General Wolffian duct/ureteric bud/collecting duct markers
Lglh2, Crb3, Cadh16, Spry1, Hnf1β and L1Cam were not
affected. The fact that mutant cells maintained expression of
generalized epithelial markers and markers of ureteric bud
derived collecting duct suggested this was not a defect in cell
specification or tissue maintenance. Secondly, expression of a
stabilized form of β-catenin in the collecting ducts prevented
the expression of several differentiation gene products. Third,
there was a tight inverse correlation between high β-catenin
activity in wildtype kidneys (as determined by expression of the
β-catenin target gene, Axin2) and differentiation of the ureteric
bud/collecting duct (as determined by ZO-1α+ and Aquaporin-
3 expression, [Iglesias et al., 2007; Jho et al., 2002 and our
study]). Finally, the premature differentiation that occurred in β-
catenin mutant cells occurred in the absence of changes in cell
proliferation, suggesting this was not an indirect consequence of
decreased rates of cell proliferation.
Wolffian ducts from Hoxb7-Cre; catnnb−/flox embryos
formed ectopic epithelial buds that led, in some cases, to
multiplexed kidneys. Interestingly, due to mosaic ablation of β-
catenin, these ectopic epithelia could be composed of either
wildtype or mutant cells but they were never mosaic. Initially
we assumed that these ectopic structures were ectopic ureteric
buds and that removal of β-catenin caused hyperactivation of
the ureteric bud branching pathway. However, molecular
analysis suggested this was not the case. Ureteric bud branching
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effectors (Costantini and Shakya, 2006). In all models of ectopic
ureteric bud formation examined to date, the GDNF/Ret
pathway appears to be ectopically activated (Basson et al.,
2005; Grieshammer et al., 2004; Kume et al., 2000; Shakya et
al., 2005). However, we saw no expansion of Gdnf mRNA
expression in the mesenchyme of mutants. In fact, mutant
epithelial cells appeared to express greatly reduced levels of
mRNA for the GDNF co-receptor, Ret. Further, the majority of
ectopic epithelia did not express the Ret target gene Wnt11
suggesting that the Ret signaling pathway was not active in
these cells. Finally, the observation that culturing mutant ducts
in the presence of a function-blocking antibody to GDNF did
not affect formation of the ectopic epithelia provided additional
support that this phenotype occurred independent of Ret/GDNF
signaling. However, it is important to note that in all cases
where ectopic buds gave rise to duplexed kidneys, the collecting
duct epithelium of the ectopic organ was genetically wildtype or
mosaic, suggesting that it was derived from a wildtype ectopic
bud (N=3). Although we found several clear cases where β-
catenin mutant epithelia invaded the MM, these mutant cells
were not capable of undergoing normal branching morphogen-
esis, presumably due to the loss of ret expression.
The data discussed above raise the question of how or why
mutant Wolffian ducts form ectopic buds? Insight into this
question came from the observation that Wolffian ducts that
were composed largely or exclusively of mutant cells had a
rough appearance but did not form ectopic epithelia or even an
endogenous ureteric bud (Fig. 8 not shown). These data
suggested that the formation of the ectopic epithelia was
dependent on the presence of both wildtype and mutant cells in
the same duct. We suggest the following explanation of these
results. Ectopic epithelial buds are actually cells that are being
extruded from the Wolffian duct. Extrusion is the result of
differential adhesiveness between wildtype and mutant cells
(i.e. wildtype cells are more adhesive to other wildtype cells
than to mutant cells and vice versa). Epithelial extrusion occurs
when cells of the two opposite genotypes (β-catenin + or −)
abut. Differential adhesiveness causes the cells of each
genotype to co-segregate with other cells of the same genotype
but to segregate away from cells of the alternate genotype. If
the majority of cells in a duct are wildtype, then mutant cells
are extruded and vice versa. If all cells are mutant (or
wildtype), no cells are extruded and therefore no ectopic buds
form. If the extruded cells are wildtype and they invade the
MM, they can support normal growth of the kidney. If more
than one wildtype population is extruded in the vicinity of the
MM, they can each branch leading to multiplexed kidneys.
However, if cells adjacent to the MM are mutant or lose β-
catenin shortly after invasion, branching ceases, at least in part
due to loss of ret expression, resulting in aplastic or hypo-
plastic organs. As the mutant ectopic epithelia do not express
markers of the ureteric bud but do express markers of the
differentiated collecting duct, they should not be called ectopic
ureteric buds.
We suggest that all of the phenotypes discussed above can be
explained by the observed premature differentiation that occursin mutant cells. Relative differences in adhesive strength
between differentiated (β-catenin −) and undifferentiated (β-
catenin +) cells (and the subsequent epithelial extrusion) may be
the result of the differential expression of ZO-1 isoforms.
Previous studies have shown that ZO-1α+ is the last component
incorporated into the developing tight junction in the mouse
blastocyst and that expression of this protein correlates with a
differentiated, rigid epithelium (Balda and Anderson, 1993;
Fleming et al., 2000; Kurihara et al., 1992; Sheth et al., 1997;
Willott et al., 1992). Premature expression of ZO-1α+ in the
mutant Wolffian ducts and ureteric bud/collecting duct system
presumably would cause these cells to be more adhesive to
other mutant/ZO-1α+-expressing cells than to wildtype,
undifferentiated cells. It will be interesting to determine whether
premature expression of ZO-1α+ alone is sufficient to lead to
differential cell adhesion and whether production of this isoform
can be used as a generalized readout for loss of β-catenin
signaling in other epithelial tissues. As alternative splicing and
inclusion or exclusion of the α+ exon determines the production
of the two ZO-1 isoforms, premature expression of the α+
isoform cannot be a direct response to loss of β-catenin.
However, β-catenin might directly regulate the expression of a
splicing factor that acts on ZO-1 pre-mRNA.
Differential adhesiveness, along with the loss of factors
necessary for ureteric bud branching (such as Ret), would
prevent further branching. We cannot rule out the possibility
that expression of some ureteric bud tip markers is directly
regulated by β-catenin. For instance, previous studies have
suggested that c-Ret is a target of canonical Wnt signaling in
PC12 cells (Zheng et al., 1996), however we do not see
expansion of c-Ret expression in the Hoxb7-Cre;catnbexon3flox
kidneys suggesting this is unlikely (data not shown). Nor can
we completely rule out the possibility that the differential
adhesiveness between wildtype and mutant cell is unrelated
to the premature differentiation and is instead the result of
an additional role for β-catenin in mediating cell adhesion.
Although previous studies have shown that, in addition to
its signaling role, β-catenin also plays a role in adherens
junction formation, TEM and molecular analysis of
Hoxb7Cre;catnb−/flox Wolffian ducts and kidneys suggested
that this structure was intact in mutant cells. This is most likely
due to functional compensation by plakoglobin, a protein that is
closely related to β-catenin, and strongly expressed in mutant
cells. However, we cannot rule out the possibility that β-catenin
plays a more subtle role, directly or indirectly, in regulating the
relative adhesive states of cells and that this is unrelated to the
premature differentiation phenotype.
Our data suggest that high levels of β-catenin signaling are
necessary to maintain the ureteric bud fate, at least in part by
keeping these cells in an undifferentiated/precursor state.
However, whether the differentiation of the entire collecting
duct system requires ablation of β-catenin activity or merely a
decrease remains an open question. The fact that some
transgenic β-catenin reporters show expression in the distal
collecting duct suggests that lower levels of β-catenin activity
may be present in this cell type (Iglesias et al., 2007; Maretto et
al., 2003). Interestingly, although all β-catenin mutant cells
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Aqp-3. It seems plausible that these two markers are
differentially responsive to β-catenin levels and it is tempting
to speculate that different levels of β-catenin may play roles in
the cortical/medullary patterning of the collecting ducts with the
highest levels necessary for precursor cell maintenance.
In summary, we have shown that Wolffian duct/ureteric bud
derived cells expressing high levels of transcriptionally active
β-catenin represent undifferentiated precursor cells. Reduction
of β-catenin activity, either as a result of normal inactivation or
genetic ablation, results in activation of the differentiation
program while expression of a signaling active version of the
protein blocks differentiation. We suggest that β-catenin levels
mediate the balance between differentiated and undifferentiated
epithelia that occurs during normal development and branching
of the collecting duct system and that disruption of this balance
and the secondary effects it has on other cellular processes, such
as cell adhesion, most likely contributes to the progression of
various diseases of epithelial tissues including kidney aplasia
and cystic hypoplasia.
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